Texas Instruments Incorporated vs State Street SPDR S&P Biotech ETF — how do they compare? Texas Instruments Incorporated trades at $291.42 (market cap $258.53B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: Texas Instruments Incorporated pays a 2% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Texas Instruments Incorporated nearer its low. Which is the better fit depends on your goals.
| TXN | XBI | |
|---|---|---|
Market Cap | $258.53B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $332.35 | $164.28 |
52-Week Low | $153.33 | $85.16 |
Enterprise Value | $267.48B | — |
Dividend Yield | 2% | — |
Signals from Pluang's Aura AI — not financial advice
Texas Instruments (TXN) trades at $284.02, down 2.47% over 24 hours, with technical signals leaning bearish. The company reported mixed recent earnings, beating Q1 2026 estimates but missing Q3 and Q4 2025. Revenue and net income have shown volatility, with 2025 figures at $17.68B and $5.00B respectively. Analysts maintain a consensus Buy rating with a $313.05 price target, indicating potential upside. Recent CFO transition news and AI-driven demand in data centers are key developments.
Outlook remains cautiously optimistic given strong profitability margins and analyst support, but risks include elevated valuation multiples and competitive pressures in the semiconductor sector. The stock's current price near support at $281 suggests a critical level for near-term direction.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →